Caumo A, Bergman RN, Cobelli C. Insulin sensitivity from meal tolerance tests in normal subjects: a minimal model index. J Clin Endocrinol Metab. 2000;85(11):4396–402.PubMedCrossRef

Pillonetto G, Caumo A, Cobelli C. Dynamic insulin sensitivity index: importance in diabetes. Am J Physiol Endocrinol Metab. 2010;298(3):E440–8.PubMedCrossRef

Bergman RN. Minimal model: perspective from 2005. Horm Res. 2005;64 Suppl 3:8–15.PubMedCrossRef

Muscelli E, et al. Autonomic and hemodynamic responses to insulin in lean and obese humans. J Clin Endocrinol Metab. 1998;83(6):2084–90.PubMedCrossRef

Steinberg HO, et al. Type II diabetes abrogates sex differences in endothelial function in premenopausal women. Circulation. 2000;101(17):2040–6.PubMedCrossRef

Nuutila P, et al. Gender and insulin sensitivity in the heart and in skeletal muscles. Studies using positron emission tomography. Diabetes. 1995;44(1):31–6.PubMedCrossRef

Saad MF, et al. Insulin and hypertension. Relationship to obesity and glucose intolerance in Pima Indians. Diabetes. 1990;39(11):1430–5.PubMedCrossRef

Ferrannini E, et al. Insulin resistance, insulin response, and obesity as indicators of metabolic risk. J Clin Endocrinol Metab. 2007;92(8):2885–92.PubMedCrossRef

Grassi G, et al. Effect of central and peripheral body fat distribution on sympathetic and baroreflex function in obese normotensives. J Hypertens. 2004;22(12):2363–9.PubMedCrossRef

Huggett RJ, et al. Sympathetic neural activation in nondiabetic metabolic syndrome and its further augmentation by hypertension. Hypertension. 2004;44(6):847–52.PubMedCrossRef

Florian JP, Pawelczyk JA. Non-esterified fatty acids increase arterial pressure via central sympathetic activation in humans. Clin Sci (Lond). 2010;118(1):61–9.CrossRef

Quilliot D, et al. Impaired autonomic control of heart rate and blood pressure in obesity: role of age and of insulin-resistance. Clin Auton Res. 2001;11(2):79–86.PubMedCrossRef

Valensi P, et al. Influence of parasympathetic dysfunction and hyperinsulinemia on the hemodynamic response to an isometric exercise in non-insulin-dependent diabetic patients. Metabolism. 1998;47(8):934–9.PubMedCrossRef

Guyton AC. Roles of the kidneys and fluid volumes in arterial pressure regulation and hypertension. Chin J Physiol. 1989;32(2):49–57.PubMed

Charra B, Chazot C. Volume control, blood pressure and cardiovascular function. Lessons from hemodialysis treatment. Nephron Physiol. 2003;93(4):94–101.CrossRef

Hall JE. Renal function in one-kidney, one-clip hypertension and low renin essential hypertension. Am J Hypertens. 1991;4(10 Pt 2):523S–33.PubMed

Hall JE. Mechanisms of abnormal renal sodium handling in obesity hypertension. Am J Hypertens. 1997;10(5 Pt 2):49S–55.PubMedCrossRef

Strazzullo P, et al. Abnormalities of renal sodium handling in the metabolic syndrome. Results of the Olivetti Heart Study. J Hypertens. 2006;24(8):1633–9.PubMedCrossRef

Chen J, et al. Metabolic syndrome and salt sensitivity of blood pressure in non-diabetic people in China: a dietary intervention study. Lancet. 2009;373(9666):829–35.PubMedCrossRef

Hoffmann IS, Cubeddu LX. Increased blood pressure reactivity to dietary salt in patients with the metabolic syndrome. J Hum Hypertens. 2007;21(6):438–44.PubMed

Steinberg HO, et al. Obesity/insulin resistance is associated with endothelial dysfunction. Implications for the syndrome of insulin resistance. J Clin Invest. 1996;97(11):2601–10.PubMedCrossRef

Sowers JR. Effects of insulin and IGF-I on vascular smooth muscle glucose and cation metabolism. Diabetes. 1996;45 Suppl 3:S47–51.PubMed

Du X, et al. Insulin resistance reduces arterial prostacyclin synthase and eNOS activities by increasing endothelial fatty acid oxidation. J Clin Invest. 2006;116(4):1071–80.PubMedCrossRef

Okon EB, et al. Compromised arterial function in human type 2 diabetic patients. Diabetes. 2005;54(8):2415–23.PubMedCrossRef

Symons JD, et al. Contribution of insulin and Akt1 signaling to endothelial nitric oxide synthase in the regulation of endothelial function and blood pressure. Circ Res. 2009;104(9):1085–94.PubMedCrossRef

Perticone F, et al. Endothelial dysfunction, ADMA and insulin resistance in essential hypertension. Int J Cardiol. 2010;142(3):236–41.PubMedCrossRef

Sydow K, Mondon CE, Cooke JP. Insulin resistance: potential role of the endogenous nitric oxide synthase inhibitor ADMA. Vasc Med. 2005;10 Suppl 1:S35–43.PubMedCrossRef

Galipeau D, et al. Chronic thromboxane synthase inhibition prevents fructose-induced hypertension. Hypertension. 2001;38(4):872–6.PubMed